DK1877409T3 - Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf - Google Patents

Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Info

Publication number
DK1877409T3
DK1877409T3 DK06743743T DK06743743T DK1877409T3 DK 1877409 T3 DK1877409 T3 DK 1877409T3 DK 06743743 T DK06743743 T DK 06743743T DK 06743743 T DK06743743 T DK 06743743T DK 1877409 T3 DK1877409 T3 DK 1877409T3
Authority
DK
Denmark
Prior art keywords
preparation
same
compositions containing
substituted pyrrolopyridines
pyrrolopyridines
Prior art date
Application number
DK06743743T
Other languages
English (en)
Inventor
Michel Tabart
Eric Bacque
Frank Halley
Pascal Desmazeau
Fabrice Viviani
Catherine Souaille
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1877409T3 publication Critical patent/DK1877409T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK06743743T 2005-04-26 2006-04-26 Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf DK1877409T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000925 WO2006114520A2 (fr) 2005-04-26 2006-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
DK1877409T3 true DK1877409T3 (da) 2009-10-05

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06743743T DK1877409T3 (da) 2005-04-26 2006-04-26 Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf

Country Status (33)

Country Link
US (1) US7947706B2 (da)
EP (1) EP1877409B1 (da)
JP (1) JP2008539211A (da)
KR (1) KR20080007229A (da)
CN (1) CN101166739A (da)
AR (1) AR061386A1 (da)
AT (1) ATE433976T1 (da)
AU (1) AU2006239105A1 (da)
BR (1) BRPI0613161A2 (da)
CA (1) CA2605744A1 (da)
CR (1) CR9463A (da)
CY (1) CY1109369T1 (da)
DE (1) DE602006007337D1 (da)
DK (1) DK1877409T3 (da)
DO (1) DOP2006000096A (da)
EA (1) EA012983B1 (da)
ES (1) ES2328629T3 (da)
FR (1) FR2884821B1 (da)
GT (1) GT200600174A (da)
HR (1) HRP20090494T1 (da)
IL (1) IL186523A0 (da)
MA (1) MA29480B1 (da)
MX (1) MX2007013084A (da)
NO (1) NO20075918L (da)
PA (1) PA8671301A1 (da)
PE (1) PE20071420A1 (da)
PL (1) PL1877409T3 (da)
PT (1) PT1877409E (da)
RS (1) RS51136B (da)
SI (1) SI1877409T1 (da)
TN (1) TNSN07360A1 (da)
TW (1) TW200718701A (da)
WO (1) WO2006114520A2 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
SG158147A1 (en) * 2006-10-09 2010-01-29 Takeda Pharmaceutical Kinase inhibitors
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
WO2008078091A1 (en) * 2006-12-22 2008-07-03 Astex Therapeutics Limited Bicyclic heterocyclic compounds as fgfr inhibitors
CN101679409B (zh) 2006-12-22 2014-11-26 Astex治疗学有限公司 双环杂环衍生化合物、其医药组合物和其用途
JP2010533729A (ja) 2007-07-17 2010-10-28 プレキシコン，インコーポレーテッド キナーゼ調節のための化合物と方法、及びそのための適応
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0810902D0 (en) * 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
KR101739994B1 (ko) 2009-04-03 2017-05-25 에프. 호프만-라 로슈 아게 프로판-１-술폰산 ｛３-［５-（４-클로로-페닐）-１Ｈ-피롤로［２，３-ｂ］피리딘-３-카르보닐］-２，４-디플루오로-페닐｝-아미드 조성물 및 그의 용도
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
NZ599866A (en) 2009-11-06 2014-09-26 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
KR101911972B1 (ko) 2011-02-07 2018-10-25 플렉시콘 인코퍼레이티드 키나제 조절을 위한 화합물 및 방법, 및 그에 대한 적응증
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
EP2855477A4 (en) * 2012-05-29 2015-11-18 Merck Sharp & Dohme ISOTOPICALLY MARKED BIARYL UREA COMPOUNDS
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
AU2002333524A1 (en) * 2001-09-11 2003-03-24 Glaxosmithkline K.K. Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
US7129225B2 (en) * 2001-10-22 2006-10-31 The Research Foundation Of State University Of New York Protection against and treatment of hearing loss
EP1490364B1 (en) * 2002-03-28 2007-09-26 Eisai R&D Management Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
FR2878849B1 (fr) * 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
WO2006114520A2 (fr) 2006-11-02
EA200702329A1 (ru) 2008-02-28
ES2328629T3 (es) 2009-11-16
CY1109369T1 (el) 2014-07-02
WO2006114520A3 (fr) 2007-03-01
MX2007013084A (es) 2008-01-11
MA29480B1 (fr) 2008-05-02
EP1877409A2 (fr) 2008-01-16
TNSN07360A1 (en) 2008-12-31
CA2605744A1 (fr) 2006-11-02
EP1877409B1 (fr) 2009-06-17
PT1877409E (pt) 2009-09-16
DE602006007337D1 (de) 2009-07-30
IL186523A0 (en) 2008-01-20
CN101166739A (zh) 2008-04-23
BRPI0613161A2 (pt) 2010-12-21
TW200718701A (en) 2007-05-16
PE20071420A1 (es) 2007-01-20
NO20075918L (no) 2007-11-19
SI1877409T1 (sl) 2009-12-31
GT200600174A (es) 2006-12-26
CR9463A (es) 2008-02-21
EA012983B1 (ru) 2010-02-26
DOP2006000096A (es) 2007-04-15
PA8671301A1 (es) 2006-12-07
RS51136B (sr) 2010-10-31
US20080139606A1 (en) 2008-06-12
US7947706B2 (en) 2011-05-24
FR2884821B1 (fr) 2007-07-06
AR061386A1 (es) 2008-08-27
JP2008539211A (ja) 2008-11-13
PL1877409T3 (pl) 2009-12-31
HRP20090494T1 (hr) 2009-10-31
ATE433976T1 (de) 2009-07-15
FR2884821A1 (fr) 2006-10-27
KR20080007229A (ko) 2008-01-17
AU2006239105A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
DK1877409T3 (da) Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf
IL187163A (en) History of fluorine, preparations containing these histories and their use
IL184524A0 (en) Substituted pyrazolo-pyridines, compositions containing them, method for the production thereof, and their use
IL198509A0 (en) Azaindole derivatives, compositions containing the same and uses thereof
IL188050A (en) The history of azaindazole, their medicinal preparations and their uses
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL187224A0 (en) Bicyclic derivatives and pharmaceutical compositions containing the same
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
ZA200801773B (en) New formulation
DK2076260T3 (da) N-methylaminomethyl-isoindol-forbindelser og sammensætninger, der indeholder disse, samt fremgangsmåder til deres anvendelse
ZA200800431B (en) Selected cgrp antagonists, methods for the production thereof and their use as medicaments
SI1888580T1 (sl) Pirido d pirimidini uporabni kot inhibitorjiHCV in postopki za njihovo pripravo
IL184111A0 (en) Prostaglandin-containing compositions and methods for enhancing the stability thereof
NO20082249L (no) Fusert heterocyklisk derivat, medisinsk sammensetning inneholdende samme samt medisinsk bruk derav
IL190017A0 (en) Bicyclic compounds and pharmaceutical compositions containing the same
IL188861A0 (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
IL189497A0 (en) Selected cgrp antagonists, methods for the production thereof and their use as medicaments
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
DK1928427T3 (da) Hidtil ukendt dosisformulering
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
DK1910288T3 (da) 3-aminocarbazolsammensætninger, farmaceutiske sammensætninger, der indeholder disse, samt fremgangsmåde til deres fremstilling
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
IL190063A (en) The history of cycloalkanes is preserved, their medicinal preparations and their uses
DE502006004524D1 (de) Verfahren zur herstellung von 3,7-diaza-bicycloä3.3.1ünonan-verbindungen